Borosil Scientific Limited
Borosil Scientific Limited (BOROSCI) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Industrials›Capital Goods›Industrial Products›Glass - Industrial
borosilscientific.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 115 Cr | 104 Cr | 103 Cr | 101 Cr | 129 Cr | 96 Cr | 107 Cr | 121 Cr | 143 Cr | 107 Cr |
| Operating expenses (approx.) | 97 Cr | 94 Cr | 87 Cr | 91 Cr | 113 Cr | 91 Cr | 99 Cr | 104 Cr | 111 Cr | 98 Cr |
| EBITDA | 18 Cr | 10 Cr | 15 Cr | 10 Cr | 17 Cr | 5 Cr | 8 Cr | 17 Cr | 32 Cr | 8 Cr |
| OPM % | 15.5% | 9.4% | 15.1% | 9.9% | 12.8% | 5.1% | 7.5% | 14.2% | 22.4% | 7.9% |
| Other income | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 3 Cr | 3 Cr | 2 Cr | 2 Cr | 2 Cr | 3 Cr |
| Interest | 0.67 Cr | 0.40 Cr | 0.36 Cr | 0.35 Cr | 0.44 Cr | 0.38 Cr | 0.23 Cr | 0.26 Cr | 0.26 Cr | 0.25 Cr |
| Depreciation | 4 Cr | 5 Cr | 5 Cr | 5 Cr | 5 Cr | 5 Cr | 5 Cr | 5 Cr | 5 Cr | 5 Cr |
| Profit before tax | 15 Cr | 7 Cr | 12 Cr | 7 Cr | 14 Cr | -4 Cr | 5 Cr | 13 Cr | 29 Cr | 6 Cr |
| Tax % | 35.3% | 28.5% | 29.1% | 38.3% | 38.6% | -3.1% | 44.5% | 31.2% | 6.5% | 27.2% |
| Net profit | 9 Cr | 5 Cr | 9 Cr | 4 Cr | 9 Cr | -4 Cr | 3 Cr | 9 Cr | 27 Cr | 4 Cr |
| EPS (₹) | ₹1.05 | ₹0.57 | ₹0.99 | ₹0.48 | ₹0.98 | ₹-0.47 | ₹0.32 | ₹0.98 | ₹3.06 | ₹0.49 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|
| Sales | 395 Cr | 438 Cr | 467 Cr | Sign in for TTM |
| Operating expenses (approx.) | 349 Cr | 386 Cr | 405 Cr | Sign in for TTM |
| EBITDA | 45 Cr | 53 Cr | 62 Cr | Sign in for TTM |
| OPM % | 11.5% | 12.0% | 13.3% | Sign in for TTM |
| Other income | 5 Cr | 8 Cr | 10 Cr | Sign in for TTM |
| Interest | 3 Cr | 2 Cr | 1 Cr | Sign in for TTM |
| Depreciation | 16 Cr | 18 Cr | 19 Cr | Sign in for TTM |
| Profit before tax | 32 Cr | 40 Cr | 43 Cr | Sign in for TTM |
| Tax % | 25.6% | 33.8% | 19.3% | Sign in for TTM |
| Net profit | 23 Cr | 27 Cr | 35 Cr | Sign in for TTM |
| EPS (₹) | ₹2.65 | ₹3.02 | ₹3.89 | Sign in for TTM |
| Dividend payout % | 0.0% | 0.0% | 0.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Equity capital | 9 Cr | 9 Cr | 9 Cr |
| Reserves | 367 Cr | 395 Cr | 432 Cr |
| Borrowings | 17 Cr | 14 Cr | 8 Cr |
| Other liabilities | 100 Cr | 90 Cr | 100 Cr |
| Total liabilities | 493 Cr | 509 Cr | 549 Cr |
| Fixed assets (net) | 124 Cr | 120 Cr | 122 Cr |
| CWIP | 0.83 Cr | 1 Cr | 9 Cr |
| Investments | 0.01 Cr | 105 Cr | 122 Cr |
| Loans & advances | 0.24 Cr | 0.19 Cr | 0.55 Cr |
| Inventories | 97 Cr | 97 Cr | 103 Cr |
| Trade receivables | 61 Cr | 71 Cr | 76 Cr |
| Cash & bank | 12 Cr | 13 Cr | 13 Cr |
| Other assets | 198 Cr | 101 Cr | 104 Cr |
| Total assets | 493 Cr | 509 Cr | 549 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Cash from operating activity | 30 Cr | 120 Cr | 43 Cr |
| Cash from investing | -2 Cr | -115 Cr | -37 Cr |
| Cash from financing | -16 Cr | -3 Cr | -6 Cr |
| Net cash flow | 12 Cr | 1 Cr | -0.15 Cr |
| Free cash flow (OCF − Capex) | 17 Cr | 106 Cr | 15 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| ROCE % | 8.7% | 10.0% | 9.8% |
| ROE % | 6.3% | 6.6% | 7.8% |
| Debtor days | 57 | 59 | 59 |
| Inventory days | 275 | 245 | 237 |
| Days payable | 115 | 88 | 98 |
| Cash conversion cycle | 217 | 215 | 199 |
| Debt / equity | 0.04 | 0.03 | 0.02 |
| Current ratio | 2.91 | 3.56 | 3.62 |
| Net debt / EBITDA | 0.10 | 0.02 | -0.08 |
Compare with peers
Loading peers…